RESPIRATORY INFECTIONS, RECURRENT, CHRONIC

Clinical trials for RESPIRATORY INFECTIONS, RECURRENT, CHRONIC explained in plain language.

Never miss a new study

Get alerted when new RESPIRATORY INFECTIONS, RECURRENT, CHRONIC trials appear

Sign up with your email to follow new studies for RESPIRATORY INFECTIONS, RECURRENT, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New inhaled therapy tested to fight stubborn lung infections in CF

Disease control Recruiting now

This study is testing the safety of a new inhaled medication called RSP-1502 for people with cystic fibrosis who have a chronic lung infection called Pseudomonas aeruginosa. Participants will breathe in the medication through a nebulizer for 14 days. The goal is to see if this tr…

Matched conditions: RESPIRATORY INFECTIONS, RECURRENT, CHRONIC

Phase: PHASE1, PHASE2 • Sponsor: Respirion Pharmaceuticals Pty Ltd • Aim: Disease control

Last updated Mar 12, 2026 13:52 UTC

RESPIRATORY INFECTIONS, RECURRENT, CHRONIC

Get alerted when new RESPIRATORY INFECTIONS, RECURRENT, CHRONIC trials appear

New inhaled therapy tested to fight stubborn lung infections in CF